ScreenerHero

IMM Immutep Ltd.

ASX · AU · Healthcare · Biotechnology · immutep.com
—Mkt Cap: —P/E: —

Immutep Limited, a clinical-stage biotechnology company, develops lymphocyte activation gene-3 (LAG-3) related immunotherapies for cancer and autoimmune diseases in Australia. The company's lead product candidate is the …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.87BUSDP/E 29.6
MRNA
Moderna, Inc.
$94.42BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$81.99BUSDP/E 19.1
ARGX
argenx SE
$53.47BUSDP/E 32.5
ARGX
argenx SE
$53.22BUSDP/E 31.6
UCB
UCB SA
$44.02BUSDP/E 17.8
ONC
BeOne Medicines AG
$42.56BUSDP/E 66.4
RVMD
Revolution Medicines, Inc.
$40.57BUSD
RPRX
Royalty Pharma plc
$34.45BUSDP/E 30.4
ALNY
Alnylam Pharmaceuticals, Inc.
$31.32BUSDP/E 39.3
ROIV
Roivant Sciences Ltd.
$24.59BUSD
GMAB
Genmab A/S
$23.32BUSDP/E 31.7
GMAB
Genmab A/S
$23.26BUSDP/E 29.8
INCY
Incyte Corporation
$22.96BUSDP/E 14.0
BNTX
BioNTech SE
$22.66BUSD
INSM
Insmed Incorporated
$21.67BUSD
EXEL
Exelixis, Inc.
$15.57BUSDP/E 19.3
ASND
Ascendis Pharma A/S
$14.91BUSDP/E 17.4
JAZZ
Jazz Pharmaceuticals plc
$13.92BUSDP/E 14.7
HALO
Halozyme Therapeutics, Inc.
$13.79BUSDP/E 33.4

Key Statistics

Company
Market Cap—
Enterprise Value-23.45M USD
Revenue (TTM)13.78M USD
Gross Profit-49.77M USD
Net Income (TTM)-54.81M USD
Revenue/Share0.01 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU000000IMM6
Valuation
P/E (Trailing)—
P/E (Forward)-2.18
PEG1.39
EV/EBITDA0.43
EV/Revenue-1.70
P/S1.77
P/B0.57
EPS (TTM)-0.05
EPS (Forward)-0.01
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin0.00%
Oper. Margin-255.74%
EBITDA Margin0.00%
Profit Margin-544.79%
ROE-128.88%
ROA-95.24%
Growth
Revenue Growth633.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-38.33M USD
CapEx (TTM)64.22K USD
FCF Margin-185.58%
FCF Yield—
Net Debt-46.87M USD
Net Debt/EBITDA0.85
Balance Sheet
Debt/Equity0.02
Current Ratio5.69
Quick Ratio5.54
Book Value/Sh0.04 AUD
Cash/Share0.05 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateNov 5, 2019
Analyst Consensus
Rating—
Target (Mean)0.1133 AUD
Target Range0.0600 AUD – 0.2000 AUD
# Analysts3
Ownership
Shares Out.1.47B
Float1.37B
Insiders3.15%
Institutions47.73%
Technical
SMA 500.0427 AUD
SMA 2000.1331 AUD
Beta2.30
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)11.41M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—